BONUSCAP-ZERTIFIKAT - ROCHE GS Share Price

Certificat

DE000HVB5UZ7

Real-time Bid/Ask 02:55:36 17/05/2024 pm IST
705.6 EUR / 712.69 EUR +1.17% Intraday chart for BONUSCAP-ZERTIFIKAT - ROCHE GS
Current month+10.98%
1 month+9.31%
Date Price Change
17/24/17 703.9 +0.43%
16/24/16 701 +6.37%
15/24/15 659 +1.21%
14/24/14 651.1 -1.33%
13/24/13 659.9 +0.49%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 01:34 pm IST

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer UniCredit UniCredit
WKN HVB5UZ
ISINDE000HVB5UZ7
Date issued 28/09/2021
Strike 384.7 CHF
Maturity 21/09/2026 (858 Days)
Parity 0.34 : 1
Emission price 1,000
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 1,138
Lowest since issue 610.9
Spread 7.08
Spread %0.99%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
234.8 CHF
Average target price
279.4 CHF
Spread / Average Target
+18.99%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW